Why is Kilitch Drugs falling/rising?

As of 28-Jul, Kilitch Drugs (India) Ltd is experiencing a rise in its stock price, currently at 440.00, reflecting an increase of 5.45 or 1.25%. The stock has shown a positive performance today, outperforming its sector by 1.17% and has been on a consecutive gain for the last two days, accumulating a total return of 3.27%. Over the past month, the stock has increased by 3.10%, while its year-to-date performance stands at an impressive 36.22%. The company has demonstrated strong financial health, with net sales growing at an annual rate of 30.05% and a significant increase in net profit of 82.17%. Additionally, the company has reported positive results for the last three consecutive quarters, contributing to the stock's upward momentum.
In the broader market context, Kilitch Drugs has outperformed the benchmark Sensex in both the short and long term, with a 1-week return of -1.15% compared to the Sensex's -1.59%, and a 1-year return of 23.77% against the Sensex's -0.54%. This indicates that while the overall market may be struggling, Kilitch Drugs has maintained a strong position. However, it is worth noting that there has been a decline in investor participation, with delivery volume falling by 10.39% against the 5-day average, which could be a concern for future trading activity. Despite this, the stock's liquidity remains sufficient for trading, suggesting that it can continue to attract investors amidst a challenging market environment.